-
2
-
-
0027230568
-
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation
-
WA May, ML Gishizky, SL Lessnick et al. Ewing sarcoma 11-22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by Flil for Transformation Proc Nati Acad Sei USA 90 12 1993 Jun 15 5752 5756 (Pubitemid 23176240)
-
(1993)
Proceedings of the National Academy of Sciences of the United States of America
, vol.90
, Issue.12
, pp. 5752-5756
-
-
May, W.A.1
Gishizky, M.L.2
Lessnick, S.L.3
Lunsford, L.B.4
Lewis, B.C.5
Delattre, O.6
Zucman, J.7
Thomas, G.8
Denny, C.T.9
-
3
-
-
80053257162
-
Ewing sarcoma family of tumors
-
W.L. Carroll J.L. Finlay Jones and Bartlett Sudbury, Massachusetts
-
JA Toretsky, H Kovar, M Paulussen et al. Ewing sarcoma family of tumors WL Carroll JL Finlay Cancer in children and adolescents 2010 Jones and Bartlett Sudbury, Massachusetts 108 395
-
(2010)
Cancer in Children and Adolescents
, pp. 108-395
-
-
Toretsky, J.A.1
Kovar, H.2
Paulussen, M.3
-
4
-
-
33845344030
-
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma
-
DOI 10.1158/1541-7786.MCR-06-0090
-
M Kinsey, R Smith, SL Lessnick NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma Mol Cancer Res 4 ll 2006 Nov 851 859 (Pubitemid 44877015)
-
(2006)
Molecular Cancer Research
, vol.4
, Issue.11
, pp. 851-859
-
-
Kinsey, M.1
Smith, R.2
Lessnick, S.L.3
-
5
-
-
0028821578
-
Multiple domains mediate transformation by the Ewings-sarcoma Ews/Fli-1 fusion gene
-
SL Lessnick, BS Braun, CT Denny, WA May Multiple domains mediate transformation by the Ewings-sarcoma Ews/Fli-1 fusion gene Oncogene 10 3 1995 Feb 2 423 431
-
(1995)
Oncogene
, vol.10
, Issue.3
, pp. 423-431
-
-
Lessnick, S.L.1
Braun, B.S.2
Denny, C.T.3
May, W.A.4
-
6
-
-
52449094980
-
Results of the EICESS-92 study: Two randomized trials of Ewing's sarcoma treatment -Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients
-
M Paulussen, AW Craft, I Lewis et al. Results of the EICESS-92 study: Two randomized trials of Ewing's sarcoma treatment -Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients J Clin Oncol 26 27 2008 Sep 20 4385 4393
-
(2008)
J Clin Oncol
, vol.26
, Issue.27
, pp. 4385-4393
-
-
Paulussen, M.1
Craft, A.W.2
Lewis, I.3
-
7
-
-
66349087641
-
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study
-
L Granowetter, R Womer, M Dévidas et al. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study JClin Oncol 27 15 2009 May 20 2536 2541
-
(2009)
JClin Oncol
, vol.27
, Issue.15
, pp. 2536-2541
-
-
Granowetter, L.1
Womer, R.2
Dévidas, M.3
-
8
-
-
79955502856
-
Nonmetastatic Ewing family tumors: High-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
-
S Ferrari, KS Hall, R Luksch et al. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol Ann Oncol 22 5 2011 May 1221 1227
-
(2011)
Ann Oncol
, vol.22
, Issue.5
, pp. 1221-1227
-
-
Ferrari, S.1
Hall, K.S.2
Luksch, R.3
-
9
-
-
75649144053
-
The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)
-
J Haeusler, A Ranft, T Boelling et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) Cancer 116 2 2010 443 450
-
(2010)
Cancer
, vol.116
, Issue.2
, pp. 443-450
-
-
Haeusler, J.1
Ranft, A.2
Boelling, T.3
-
10
-
-
77954727583
-
Primary disseminated multifocal Ewing sarcoma: Results of the Euro-EWING 99 trial
-
R Ladenstein, U Potschger, MC Le Deley et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial JClin Oncol 28 20 2010 Jul 10 3284 3291
-
(2010)
JClin Oncol
, vol.28
, Issue.20
, pp. 3284-3291
-
-
Ladenstein, R.1
Potschger, U.2
Le Deley, M.C.3
-
11
-
-
80053062871
-
Preliminary efficacy of the Anti-Insulin like Growth Factor type 1 Receptor antibody figitumumab in patients with refractory Ewing sarcoma
-
in press.
-
H Juergens, NC Daw, B Geoerger et al. Preliminary efficacy of the Anti-Insulin like Growth Factor type 1 Receptor antibody figitumumab in patients with refractory Ewing sarcoma J Clin Oncol 2011 in press.
-
(2011)
J Clin Oncol
-
-
Juergens, H.1
Daw, N.C.2
Geoerger, B.3
-
12
-
-
77954685904
-
Approaching Ewing sarcoma
-
U Dirksen, H Jürgens Approaching Ewing sarcoma Future Oncol 6 7 2010 1155 1162
-
(2010)
Future Oncol
, vol.6
, Issue.7
, pp. 1155-1162
-
-
Dirksen, U.1
Jürgens, H.2
-
13
-
-
61449097712
-
The role of IGF-1R in pédiatrie malignancies
-
SY Kim, JA Toretsky, D Scher, LJ Helman The role of IGF-1R in pédiatrie malignancies Oncologist 14 1 2009 83 91
-
(2009)
Oncologist
, vol.14
, Issue.1
, pp. 83-91
-
-
Kim, S.Y.1
Toretsky, J.A.2
Scher, D.3
Helman, L.J.4
|